Lineage Cell Therapeutics
LCTX
#8900
Rank
โ‚ฌ93.49 M
Marketcap
0,40ย โ‚ฌ
Share price
-6.12%
Change (1 day)
-61.53%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -0,12ย โ‚ฌ

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,11ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,13ย โ‚ฌ an increase over its 2021 EPS that were of -0,23ย โ‚ฌ.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,12ย โ‚ฌ-5.72%
2022-0,13ย โ‚ฌ-42.31%
2021-0,23ย โ‚ฌ85.71%
2020-0,12ย โ‚ฌ250%
2019-0,03501ย โ‚ฌ-88.57%
2018-0,31ย โ‚ฌ105.88%
2017-0,15ย โ‚ฌ-153.13%
20160,28ย โ‚ฌ-154.24%
2015-0,52ย โ‚ฌ5.36%
2014-0,49ย โ‚ฌ-30.86%
2013-0,71ย โ‚ฌ88.37%
2012-0,38ย โ‚ฌ19.44%
2011-0,32ย โ‚ฌ33.33%
2010-0,24ย โ‚ฌ68.75%
2009-0,14ย โ‚ฌ-5.88%
2008-0,15ย โ‚ฌ183.33%
2007-0,05251ย โ‚ฌ-25%
2006-0,07002ย โ‚ฌ-27.27%
2005-0,09627ย โ‚ฌ-38.89%
2004-0,16ย โ‚ฌ38.46%
2003-0,11ย โ‚ฌ-43.48%
2002-0,20ย โ‚ฌ-26.63%
2001-0,27ย โ‚ฌ-28.75%
2000-0,39ย โ‚ฌ-10.4%
1999-0,43ย โ‚ฌ
1997-0,28ย โ‚ฌ3.13%
1996-0,27ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,91ย โ‚ฌ 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA